Home Cart 0 Sign in  
X

[ CAS No. 4513-94-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 4513-94-4
Chemical Structure| 4513-94-4
Chemical Structure| 4513-94-4
Structure of 4513-94-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4513-94-4 ]

Related Doc. of [ 4513-94-4 ]

Alternatived Products of [ 4513-94-4 ]

Product Details of [ 4513-94-4 ]

CAS No. :4513-94-4 MDL No. :MFCD00234061
Formula : C5H4N2 Boiling Point : -
Linear Structure Formula :- InChI Key :BQMPGKPTOHKYHS-UHFFFAOYSA-N
M.W : 92.10 Pubchem ID :138277
Synonyms :

Calculated chemistry of [ 4513-94-4 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 25.51
TPSA : 39.58 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.32 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.09
Log Po/w (XLOGP3) : 0.76
Log Po/w (WLOGP) : 0.89
Log Po/w (MLOGP) : -0.56
Log Po/w (SILICOS-IT) : 1.43
Consensus Log Po/w : 0.72

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.42
Solubility : 3.51 mg/ml ; 0.0382 mol/l
Class : Very soluble
Log S (Ali) : -1.17
Solubility : 6.21 mg/ml ; 0.0674 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.6
Solubility : 2.31 mg/ml ; 0.0251 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.56

Safety of [ 4513-94-4 ]

Signal Word:Danger Class:9
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P362+P364-P403+P233-P501 UN#:3082
Hazard Statements:H302-H315-H318-H335-H410 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 4513-94-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4513-94-4 ]
  • Downstream synthetic route of [ 4513-94-4 ]

[ 4513-94-4 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 4513-94-4 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 2
  • [ 4513-94-4 ]
  • [ 67-66-3 ]
  • [ 89809-64-3 ]
  • [ 38180-46-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 3
  • [ 930-36-9 ]
  • [ 67-66-3 ]
  • [ 4513-94-4 ]
  • [ 1722-12-9 ]
  • [ 51269-82-0 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 24, p. 3581 - 3585
[2] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 24, p. 3581 - 3585
  • 4
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 4513-94-4 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 5
  • [ 4513-94-4 ]
  • [ 69807-81-4 ]
Reference: [1] Tetrahedron, 1998, vol. 54, # 10, p. 2021 - 2030
  • 6
  • [ 13600-33-4 ]
  • [ 4513-94-4 ]
  • [ 7126-38-7 ]
Reference: [1] Beilstein Journal of Organic Chemistry, 2013, vol. 9, p. 743 - 753
  • 7
  • [ 1120-87-2 ]
  • [ 4513-94-4 ]
  • [ 7126-38-7 ]
Reference: [1] Beilstein Journal of Organic Chemistry, 2013, vol. 9, p. 754 - 760
  • 8
  • [ 39910-67-3 ]
  • [ 4513-94-4 ]
  • [ 7126-38-7 ]
Reference: [1] Beilstein Journal of Organic Chemistry, 2013, vol. 9, p. 754 - 760
  • 9
  • [ 16289-54-6 ]
  • [ 4513-94-4 ]
  • [ 51392-75-7 ]
  • [ 2632-99-7 ]
  • [ 7126-38-7 ]
Reference: [1] Beilstein Journal of Organic Chemistry, 2013, vol. 9, p. 754 - 760
  • 10
  • [ 10296-29-4 ]
  • [ 4513-94-4 ]
  • [ 7126-38-7 ]
Reference: [1] Beilstein Journal of Organic Chemistry, 2013, vol. 9, p. 743 - 753
  • 11
  • [ 16544-33-5 ]
  • [ 4513-94-4 ]
  • [ 10479-84-2 ]
  • [ 24442-69-1 ]
  • [ 33555-85-0 ]
  • [ 91028-12-5 ]
  • [ 7126-38-7 ]
Reference: [1] Journal of Organic Chemistry, 2010, vol. 75, # 5, p. 1600 - 1611
  • 12
  • [ 274-87-3 ]
  • [ 504-29-0 ]
  • [ 4513-94-4 ]
  • [ 91028-12-5 ]
  • [ 7126-38-7 ]
Reference: [1] Journal of Organic Chemistry, 2008, vol. 73, # 16, p. 6265 - 6267
  • 13
  • [ 5678-33-1 ]
  • [ 504-29-0 ]
  • [ 4513-94-4 ]
  • [ 91028-12-5 ]
  • [ 7126-38-7 ]
Reference: [1] Journal of Organic Chemistry, 2008, vol. 73, # 16, p. 6265 - 6267
  • 14
  • [ 4513-94-4 ]
  • [ 67-66-3 ]
  • [ 89809-64-3 ]
  • [ 38180-46-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 15
  • [ 4513-94-4 ]
  • [ 159326-69-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 4, p. 1429 - 1440
[2] Patent: WO2016/190847, 2016, A1,
[3] Patent: CN104003990, 2017, B,
[4] Patent: CN104974163, 2017, B,
  • 16
  • [ 4513-94-4 ]
  • [ 136927-63-4 ]
Reference: [1] Patent: WO2007/38387, 2007, A2, . Location in patent: Page/Page column 80
  • 17
  • [ 4513-94-4 ]
  • [ 918538-04-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 4, p. 1429 - 1440
[2] Patent: WO2016/190847, 2016, A1,
[3] Patent: CN104003990, 2017, B,
[4] Patent: CN104974163, 2017, B,
  • 18
  • [ 4513-94-4 ]
  • [ 918538-05-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 4, p. 1429 - 1440
[2] Patent: WO2016/190847, 2016, A1,
[3] Patent: CN104003990, 2017, B,
[4] Patent: CN104974163, 2017, B,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4513-94-4 ]

Nitriles

Chemical Structure| 3009-97-0

[ 3009-97-0 ]

2-(Phenylamino)acetonitrile

Similarity: 0.73

Chemical Structure| 57097-45-7

[ 57097-45-7 ]

4-Chloro-1H-pyrrole-2-carbonitrile

Similarity: 0.70

Chemical Structure| 2182-39-0

[ 2182-39-0 ]

2-(Phenylamino)propanenitrile

Similarity: 0.69

Chemical Structure| 36193-65-4

[ 36193-65-4 ]

1H-Indole-2-carbonitrile

Similarity: 0.68

Chemical Structure| 1513412-80-0

[ 1513412-80-0 ]

6-Methyl-1H-indole-2-carbonitrile

Similarity: 0.68

Related Parent Nucleus of
[ 4513-94-4 ]

Pyrroles

Chemical Structure| 636-41-9

[ 636-41-9 ]

2-Methyl-1H-pyrrole

Similarity: 0.75

Chemical Structure| 625-84-3

[ 625-84-3 ]

2,5-Dimethyl-1H-pyrrole

Similarity: 0.72

Chemical Structure| 57097-45-7

[ 57097-45-7 ]

4-Chloro-1H-pyrrole-2-carbonitrile

Similarity: 0.70

Chemical Structure| 1351479-09-8

[ 1351479-09-8 ]

(1H-Pyrrol-2-yl)methanamine hydrochloride

Similarity: 0.62

Chemical Structure| 1003-29-8

[ 1003-29-8 ]

1H-Pyrrole-2-carbaldehyde

Similarity: 0.62